Evidence map›Paper›PMID 35681702›Full record

ArticleCancers2022

Exercise and Prebiotic Fiber Provide Gut Microbiota-Driven Benefit in a Survivor to Germ-Free Mouse Translational Model of Breast Cancer.

Kara Sampsell, Weilan Wang, Christina Ohland, Lukas F Mager, Nicola Pett, Dana E Lowry, Kate M Sales, Margaret L McNeely, Kathy D McCoy, S Nicole Culos-Reed and 1 more

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Effects of exercise on gut microbiota in patients with cancer: a scoping review.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. The oncobiome; what, so what, now what?Microbiome research reports · 2025
    Review
  11. Article
  12. Fecal microbial transplants as investigative tools in cancer.American journal of physiology. Gastrointestinal and liver physiology · 2024
    Review
  13. BMJ open · 2024
    Article
  14. Prebiotics: Ignored player in the fight against cancer.Cancer reports (Hoboken, N.J.) · 2023
    Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Kara SampsellFaculty of Kinesiology, University of Calgary, Calgary, AB T2N 1N4, Canada.ORCID 0000-0002-9525-9976
Weilan WangFaculty of Kinesiology, University of Calgary, Calgary, AB T2N 1N4, Canada.
Christina OhlandInternational Microbiome Centre, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada.
Lukas F MagerDepartment of Physiology and Pharmacology, Snyder Institute of Chronic Diseases, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada.
Nicola PettInternational Microbiome Centre, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada.
Dana E LowryFaculty of Kinesiology, University of Calgary, Calgary, AB T2N 1N4, Canada.
Kate M SalesFaculty of Kinesiology, University of Calgary, Calgary, AB T2N 1N4, Canada.
Margaret L McNeelyDepartment of Physical Therapy, University of Alberta, Edmonton, AB T6G 2R3, Canada.ORCID 0000-0003-4376-4847
Kathy D McCoyDepartment of Physiology and Pharmacology, Snyder Institute of Chronic Diseases, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada.
S Nicole Culos-ReedFaculty of Kinesiology, University of Calgary, Calgary, AB T2N 1N4, Canada.
Raylene A ReimerFaculty of Kinesiology, University of Calgary, Calgary, AB T2N 1N4, Canada.ORCID 0000-0001-5088-7947
University of Calgary · CAUniversity of Alberta · CA

Funding

Alberta Cancer Foundation GrantAlberta Innovates Cancer Prevention Research OpportunityUniversity of Calgary VPR Catalyst Grant
6 · The paper itself

Abstract

The gut microbiota plays a role in shaping overall host health and response to several cancer treatments. Factors, such as diet, exercise, and chemotherapy, can alter the gut microbiota. In the present study, the Alberta Cancer Exercise (ACE) program was investigated as a strategy to favorably modify the gut microbiota of breast cancer survivors who had received chemotherapy. Subsequently, the ability of post-exercise gut microbiota, alone or with prebiotic fiber supplementation, to influence breast cancer outcomes was interrogated using fecal microbiota transplant (FMT) in germ-free mice. While cancer survivors experienced little gut microbial change following ACE, in the mice, tumor volume trended consistently lower over time in mice colonized with post-exercise compared to pre-exercise microbiota with significant differences on days 16 and 22. Beta diversity analysis revealed that EO771 breast tumor cell injection and Paclitaxel chemotherapy altered the gut microbial communities in mice. Enrichment of potentially protective microbes was found in post-exercise microbiota groups. Tumors of mice colonized with post-exercise microbiota exhibited more favorable cytokine profiles, including decreased vascular endothelial growth factor (VEGF) levels. Beneficial microbial and molecular outcomes were augmented with prebiotic supplementation. Exercise and prebiotic fiber demonstrated adjuvant action, potentially via an enhanced anti-tumor immune response modulated by advantageous gut microbial shifts.

Indexed as

breast cancerchemotherapyexercisefecal microbiota transplantgut microbiotaprebiotics

Identifiers

PMID35681702
PMCPMC9179252
OpenAlexW4281613161

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.